PENNSYLVANIA AMERICAN WATER COMPLETES WATER LINE UPGRADES FOR BANGOR SYSTEM

Project replaced outdated water main dating back to early 1950s

 

BANGOR, Pa. (July 5, 2017) – Pennsylvania American Water today reported the completion of upgrades to approximately 700 feet of water main along North 5th Street to improve reliability for customers, reduce service disruptions and increase water flows for firefighting. The cost of the system improvements, which replaced water main dating back to the 1950s, was more than $155,000.

 

The project, which began in late May, replaced nearly 700 feet of existing six-inch water main with new eight-inch ductile iron pipe along North 5th Street, between Market Street and Pennsylvania Avenue. 

 

 

The company expects to complete transfer of all customer services, final restoration, and paving in the fall of 2017.

 

For more information, contact Pennsylvania American Water’s customer service center at 1-800-565-7292.

 

Pennsylvania American Water, a subsidiary of American Water (NYSE: AWK), is the largest investor-owned water utility in the state, providing high-quality and reliable water and/or wastewater services to approximately 2.3 million people. With a history dating back to 1886, American Water is the largest and most geographically diverse U.S. publicly-traded water and wastewater utility company. The company employs more than 6,800 dedicated professionals who provide regulated and market-based drinking water, wastewater and other related services to an estimated 15 million people in 47 states and Ontario, Canada. More information can be found by visiting www.amwater.com

 

This release contains forward looking statements, including, among others, our plan to continue our long-term strategy of capital investment in our systems. There are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements including: general economic business conditions, unfavorable weather conditions, changes in regulations or regulatory treatment and availability and the cost of capital. We undertake no obligation to publicly update or revise any forward-looking statement.